NEW YORK – Ansa Biotechnologies said on Monday that it has raised $7.9 million in an oversubscribed seed funding round.
Horizon Ventures led the round, with participation from Mubadala Capital, Humboldt Fund, and additional investors.
Together with a pre-seed round in late December 2018 led by Fifty Years, Ansa has raised $9.2 million in total.
The latest funding will allow the company to accelerate development of its DNA synthesis technology, hire staff, build an R&D facility, and establish industrial partnerships.